Crossmark

Interventional therapy combined with tyrosine kinase inhibitors with or without immune checkpoint inhibitors as initial treatment for hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1007/s12672-024-01026-9

Published Online: 2024-05-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Du, Changjie

Wu, Hongyu

Zhong, Tao

Zhai, Qilong

Yuan, Jiajun

Peng, Jialun

Ma, Rong https://orcid.org/0000-0001-8091-466X
Li, Jinzheng https://orcid.org/0000-0003-3586-969X
Funding

Funding for this research was provided by:

the second affiliated hospital of Chongqing Medical University (CSTB2022NSCQ-MSX0821)

Chongqing Health Commission and Science and Technology Bureau (2022GDRC004)
License Information

Text and Data Mining valid from 2024-05-14

Version of Record valid from 2024-05-14
More Information

Article History

Received: 27 February 2024

Accepted: 8 May 2024

First Online: 14 May 2024

Declarations

:

: Not applicable.

: All authors approved the content and submission.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below